WallStreetZenWallStreetZen

NASDAQ: ACXP
Acurx Pharmaceuticals Inc Stock

$3.21+0.07 (+2.23%)
Updated Mar 22, 2023
ACXP Price
$3.21
Fair Value Price
N/A
Market Cap
$37.35M
52 Week Low
$2.33
52 Week High
$4.85
P/E
-2.87x
P/B
5.11x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
-$12.09M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
0.28
Operating Cash Flow
-$8M
Beta
0.44
Next Earnings
May 10, 2023
Ex-Dividend
N/A
Next Dividend
N/A

ACXP Overview

Acurx Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company developing antibiotics to treat bacterial infections. Its lead candidate is ibezapolstat to treat patients with clostridium difficile infections. Acurx is also developing ACX-375C, a treatment targeting gram-positive bacteria, including methicillin-resistant staphylococcus aureus, vancomycin-resistant enterococcus, and penicillin-resistant streptococcus pneumoniae. Acurx Pharmaceuticals was incorporated in 2017 and is headquartered in Staten Island, NY.

Zen Score

Industry Average (28)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how ACXP scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

ACXP is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
ACXP is poor value based on its book value relative to its share price (5.11x), compared to the US Biotechnology industry average (4.76x)
P/B vs Industry Valuation
ACXP is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more ACXP due diligence checks available for Premium users.

Be the first to know about important ACXP news, forecast changes, insider trades & much more!

ACXP News

Valuation

ACXP fair value

Fair Value of ACXP stock based on Discounted Cash Flow (DCF)
Price
$3.21
Fair Value
$4.75
Undervalued by
32.44%
ACXP is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

ACXP price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-2.87x
Industry
16.9x
Market
22.44x

ACXP price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
5.11x
Industry
4.76x
ACXP is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation

ACXP's financial health

Profit margin

Revenue
$0.0
Net Income
-$3.3M
Profit Margin
0%
ACXP's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials

Assets to liabilities

Assets
$9.4M
Liabilities
$2.1M
Debt to equity
0.28
ACXP's short-term assets ($9.38M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
ACXP's short-term assets ($9.38M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
ACXP's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$1.5M
Investing
$0.0
Financing
-$1.0
ACXP's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

ACXP vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
ACXP$37.35M+2.23%-2.87x5.11x
NYMX$37.14M+14.65%-4.07x48.05x
PMN$37.75M-3.72%-1.83x-28.01x
ORGS$36.84M-6.29%2.27x1.34x
PPBT$38.07M-1.44%-0.17x0.81x

Acurx Pharmaceuticals Stock FAQ

What is Acurx Pharmaceuticals's quote symbol?

NASDAQ: ACXP) Acurx Pharmaceuticals trades on the NASDAQ under the ticker symbol ACXP. Acurx Pharmaceuticals stock quotes can also be displayed as NASDAQ: ACXP.

If you're new to stock investing, here's how to buy Acurx Pharmaceuticals stock.

What is the 52 week high and low for Acurx Pharmaceuticals (NASDAQ: ACXP)?

(NASDAQ: ACXP) Acurx Pharmaceuticals's 52-week high was $4.85, and its 52-week low was $2.33. It is currently -33.81% from its 52-week high and 37.77% from its 52-week low.

How much is Acurx Pharmaceuticals stock worth today?

(NASDAQ: ACXP) Acurx Pharmaceuticals currently has 11,635,795 outstanding shares. With Acurx Pharmaceuticals stock trading at $3.21 per share, the total value of Acurx Pharmaceuticals stock (market capitalization) is $37.35M.

Acurx Pharmaceuticals stock was originally listed at a price of $7.89 in Jun 25, 2021. If you had invested in Acurx Pharmaceuticals stock at $7.89, your return over the last 1 years would have been -59.32%, for an annualized return of -59.32% (not including any dividends or dividend reinvestments).

How much is Acurx Pharmaceuticals's stock price per share?

(NASDAQ: ACXP) Acurx Pharmaceuticals stock price per share is $3.21 today (as of Mar 22, 2023).

What is Acurx Pharmaceuticals's Market Cap?

(NASDAQ: ACXP) Acurx Pharmaceuticals's market cap is $37.35M, as of Mar 24, 2023.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Acurx Pharmaceuticals's market cap is calculated by multiplying ACXP's current stock price of $3.21 by ACXP's total outstanding shares of 11,635,795.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.